Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1999 1
2000 1
2003 1
2013 1
2014 4
2018 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Bridging the gap between vaccination with Bacille Calmette-Guerin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis.
Ristori G, Faustman D, Matarese G, Romano S, Salvetti M. Ristori G, et al. Curr Opin Immunol. 2018 Dec;55:89-96. doi: 10.1016/j.coi.2018.09.016. Epub 2018 Nov 15. Curr Opin Immunol. 2018. PMID: 30447407 Review.
At the end of past century, when the prevailing view was that treatment of autoimmunity required immune suppression, experimental evidence suggested an approach of immune-stimulation such as with the BCG vaccine in type 1 diabetes (T1D) and multiple sclerosis (MS). Transla …
At the end of past century, when the prevailing view was that treatment of autoimmunity required immune suppression, experimental evidence s …
Author response.
Ristori G, Romano S, Coarelli G, Buscarinu MC, Salvetti M. Ristori G, et al. Neurology. 2014 Jul 22;83(4):381. Neurology. 2014. PMID: 25184184 No abstract available.
Author response.
Ristori G, Romano S, Coarelli G, Buscarinu MC, Salvetti M. Ristori G, et al. Neurology. 2014 Jul 15;83(3):293. Neurology. 2014. PMID: 25157390 No abstract available.
Use of Bacille Calmette-Guerin (BCG) in multiple sclerosis.
Ristori G, Buzzi MG, Sabatini U, Giugni E, Bastianello S, Viselli F, Buttinelli C, Ruggieri S, Colonnese C, Pozzilli C, Salvetti M. Ristori G, et al. Neurology. 1999 Oct 22;53(7):1588-9. doi: 10.1212/wnl.53.7.1588. Neurology. 1999. PMID: 10534275 Clinical Trial.
We studied the effect of Bacille Calmette-Guerin (BCG) vaccine as an immunomodulator in MS. According to the guidelines for clinical trials in MS, a single crossover, MRI-monitored trial was performed in 14 patients with relapsing-remitting MS. ...No major adverse effects …
We studied the effect of Bacille Calmette-Guerin (BCG) vaccine as an immunomodulator in MS. According to the guidelines for clinical …
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M. Ristori G, et al. Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4. Neurology. 2014. PMID: 24306002 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate Bacille Calmette-Guerin (BCG) effects after clinically isolated syndromes (CIS). METHODS: In a double-blind, placebo-controlled trial, participants were randomly assigned to receive BCG or placebo and monitored monthly with brain MRI (6 scans) …
OBJECTIVE: To evaluate Bacille Calmette-Guerin (BCG) effects after clinically isolated syndromes (CIS). METHODS: In a double-blind, p …
Design of immunization programmes for developing countries.
Henderson DA, Labusquire R, Nicholson CC, Rey M, Ristori C, Dow PJ, Saroso JS, Millar JD. Henderson DA, et al. Paediatr Indones. 1972 Oct;12(10):409-26. Paediatr Indones. 1972. PMID: 4679478
Selection of vaccines is treated in a separate appendix, but generally 3 groups are recognized: 1) recommended for general use: smallpox, diphtheria, tetanus, pertussis, BCG, typhoid and measles; 2) recommended for special cases: polio and yellow fever; 3) not recommended …
Selection of vaccines is treated in a separate appendix, but generally 3 groups are recognized: 1) recommended for general use: smallpox, di …
11 results